These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 3899397)

  • 1. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
    de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
    Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
    de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
    Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
    Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
    Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
    Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
    Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK
    Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
    Myint PT; Shwe T
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM
    Bull World Health Organ; 1983; 61(5):815-20. PubMed ID: 6360401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
    Tin F; Hlaing N; Tun T; Win S; Lasserre R
    Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM
    Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
    Botero D; Restrepo M; Montoya A
    Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.
    Hall AP; Doberstyn EB; Karnchanachetanee C; Samransamruajkit S; Laixuthai B; Pearlman EJ; Lampe RM; Miller CF; Phintuyothin P
    Br Med J; 1977 Jun; 1(6077):1626-8. PubMed ID: 326337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of falciparum malaria with sulfalene-pyrimethamine versus sulfadoxine-pyrimethamine.
    Chongsuphajaisiddhi T; Youngchaiyudha S; Rungpitarangsri V; Trishnananda M; Ruksakul T; Charnond L; Boonamrung S
    Southeast Asian J Trop Med Public Health; 1980 Dec; 11(4):524-7. PubMed ID: 7013094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
    Niklewski G; Landscheidt H; Glasner H
    Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
    [No Abstract]   [Full Text] [Related]  

  • 18. Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine.
    Doberstyn EB; Phintuyothin P; Noeypatimanondh S; Teerakiartkamjorn C
    Bull World Health Organ; 1979; 57(2):275-9. PubMed ID: 373903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of fansimef in Indian patients of P. falciparum malaria.
    Asthana OP; Tangri AN; Nityanand S
    Indian J Malariol; 1988 Dec; 25(2):89-96. PubMed ID: 3077373
    [No Abstract]   [Full Text] [Related]  

  • 20. Falciparum malaria resistant to quinine and pyrimethamine-sulfadoxine successfully treated with mefloquine.
    Malin AS; Hall AP
    BMJ; 1990 May; 300(6733):1175. PubMed ID: 2189516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.